drugset / Trial / NCT05229042
A Study to Investigate the Safety and Efficacy of Ricolinostat
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a double-blind, placebo-controlled study during which patients will receive ricolinostat or placebo.
Timeline
- Start
- 2022-01-01
- Primary completion
- 2023-11-10
- Completion
- 2023-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ricolinostat | Small molecule | — | Oral |